These compounds are large peptide molecules, meaning they are broken down by stomach acid and intestinal enzymes rather than absorbed intact into the bloodstream
Hodgkins CC, Cahill KS, Seraphine AE, Frost-Pineda K, Gold MS
Prescription of DPP-4 inhibitors to type 2 diabetes mellitus patients with renal impairment: a UK primary care experience
This is the ladder documented in the Wegovy prescribing information and mirrored in the STEP trial program
For GLP-1 weight-loss medications, large-scale studies tested a range of dosages to determine the specific doses that work well to help people lose and maintain their weight
If the patient has type 2 diabetes, moderate-to-severe OSA, or MASH, can they use the Bridge if their Part D plan denies coverage